IBT julkaisut 2000
NOTE: This list is not exhaustive because it has been collected by an automatic procedure from PubMed. It may also contain publications not related to IMT or Regea authors (authors having the same name). The same publication may also appear more than once in case several research groups have participated in the writing. |
| Vihinen M, Lehvaslaiho H [Genetic databases and their use] Duodecim 2000 ;116(16)1759-62 PMID |
| Notarangelo LD, Giliani S, Mazza C, Mella P, Savoldi G, Rodriguez-Perez C, Mazzolari E, Fiorini M, Duse M, Plebani A, Ugazio AG, Vihinen M, Candotti F, Schumacher RF Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol Rev 2000 ;17839-48 PMID |
| Valiaho J, Riikonen P, Vihinen M Novel immunodeficiency data servers. Immunol Rev 2000 ;178177-85 PMID |
| Siermala M, Juhola M, Vihinen M Neural network prediction of polyproline type II secondary structures. Stud Health Technol Inform 2000 ;77475-9 PMID |
| Mattsson PT, Lappalainen I, Backesjo CM, Brockmann E, Lauren S, Vihinen M, Smith CI Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis. J Immunol 2000 ;164(8)4170-7 PMID |
| Rong SB, Vihinen M Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain. J Mol Med 2000 ;78(9)530-7 PMID |
| Vihinen M, Mattsson PT, Smith CI Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA). Front Biosci 2000 ;5D917-28 PMID |
| Nera KP, Brockmann E, Vihinen M, Smith CI, Mattsson PT Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies. Protein Expr Purif 2000 ;20(3)365-71 PMID |
| Lindfors K, Halttunen T, Huotari P, Nupponen N, Vihinen M, Visakorpi T, Maki M, Kainulainen H Identification of novel transcription factor-like gene from human intestinal cells. Biochem Biophys Res Commun 2000 ;276(2)660-6 PMID |
| Korpi M, Valiaho J, Vihinen M Structure-function effects in primary immunodeficiencies. Scand J Immunol 2000 ;52(3)226-32 PMID |
| Rong SB, Valiaho J, Vihinen M Structural basis of Bloom syndrome (BS) causing mutations in the BLM helicase domain. Mol Med 2000 ;6(3)155-64 PMID |
| Vihinen M, Villa A, Mella P, Schumacher RF, Savoldi G, O'Shea JJ, Candotti F, Notarangelo LD Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency. Clin Immunol 2000 ;96(2)108-18 PMID |
| Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K, Antonarakis SE, Shimizu N, Kudoh J, Peterson P Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 2000 ;65(3)293-8 PMID |
| Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000 ;275(22)16802-9 PMID |
| Lappalainen I, Giliani S, Franceschini R, Bonnefoy JY, Duckett C, Notarangelo LD, Vihinen M Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease. Biochem Biophys Res Commun 2000 ;269(1)124-30 PMID |
| Stenberg KA, Riikonen PT, Vihinen M KinMutBase, a database of human disease-causing protein kinase mutations. Nucleic Acids Res 2000 ;28(1)369-71 PMID |
| Isola J, Järvinen T, Tanner M, Holli K [HER-2/neu oncogene in the selection of treatment for breast cancer and as a target of immunotherapy]. Duodecim 2000 ;116(15)1538-46 PMID |
| Miettinen HE, Järvinen TA, Kellner U, Kauraniemi P, Parwaresch R, Rantala I, Kalimo H, Paljärvi L, Isola J, Haapasalo H High topoisomerase IIalpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas. Neuropathol Appl Neurobiol 2000 ;26(6)504-12 PMID |
| Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000 ;157(5)1467-72 PMID |
| Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, Olsson H, Trent JM, Isola J, Borg A MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 2000 ;60(19)5323-8 PMID |
| Kytölä S, Farnebo F, Obara T, Isola J, Grimelius L, Farnebo LO, Sandelin K, Larsson C Patterns of chromosomal imbalances in parathyroid carcinomas. Am J Pathol 2000 ;157(2)579-86 PMID |
| Staff S, Nupponen NN, Borg A, Isola JJ, Tanner MM Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers. Genes Chromosomes Cancer 2000 ;28(4)432-42 PMID |
| Kytölä S, Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J, Larsson C Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer 2000 ;28(3)308-17 PMID |
| Nupponen NN, Isola J, Visakorpi T Mapping the amplification of EIF3S3 in breast and prostate cancer. Genes Chromosomes Cancer 2000 ;28(2)203-10 PMID |
| Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000 ;6(5)1833-9 PMID |
| Borg A, Isola J, Chen J, Rubio C, Johansson U, Werelius B, Lindblom A Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer 2000 ;85(6)796-800 PMID |
| Järvinen TA, Tanner M, Rantanen V, Bärlund M, Borg A, Grénman S, Isola J Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 2000 ;156(3)839-47 PMID |
| Ferri GL, Isola J, Berger P, Giro G Direct eye visualization of Cy5 fluorescence for immunocytochemistry and in situ hybridization. J Histochem Cytochem 2000 ;48(3)437-44 PMID |
| Järvinen TA, Pelto-Huikko M, Holli K, Isola J Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 2000 ;156(1)29-35 PMID |
| Bruyere K, Bermond F, Bouquet R, Caire Y, Ramet M, Voiglio E Human maxilla bone response to 30 degrees oriented impacts and comparison with frontal bone impacts. Annu Proc Assoc Adv Automot Med 2000 ;44219-34 PMID |
| Ramet M, Haataja R, Marttila R, Hamalainen AM, Knip M, Hallman M Human surfactant protein--A gene locus for genetic studies in the Finnish population. Dis Markers 2000 ;16(3-4)119-24 PMID |
| Haataja R, Ramet M, Marttila R, Hallman M Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000 ;9(18)2751-60 PMID |
| Ramet M, Haataja R, Marttila R, Floros J, Hallman M Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 2000 ;66(5)1569-79 PMID |
| Manninen A, Renkema GH, Saksela K Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway. J Biol Chem 2000 ;275(22)16513-7 PMID |
| Renkema GH, Saksela K Interactions of HIV-1 NEF with cellular signal transducing proteins. Front Biosci 2000 ;5D268-83 PMID |
| Kajander OA, Rovio AT, Majamaa K, Poulton J, Spelbrink JN, Holt IJ, Karhunen PJ, Jacobs HT Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states. Hum Mol Genet 2000 ;9(19)2821-35 PMID |
| Juhola MK, Shah ZH, Grivell LA, Jacobs HT The mitochondrial inner membrane AAA metalloprotease family in metazoans. FEBS Lett 2000 ;481(2)91-5 PMID |
| Shah ZH, Hakkaart GA, Arku B, de Jong L, van der Spek H, Grivell LA, Jacobs HT The human homologue of the yeast mitochondrial AAA metalloprotease Yme1p complements a yeast yme1 disruptant. FEBS Lett 2000 ;478(3)267-70 PMID |
| Jacobs HT, Lehtinen SK, Spelbrink JN No sex please, we're mitochondria: a hypothesis on the somatic unit of inheritance of mammalian mtDNA. Bioessays 2000 ;22(6)564-72 PMID |
| Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, Lehtinen SK, Lecrenier N, Back JW, Speijer D, Foury F, Jacobs HT In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem 2000 ;275(32)24818-28 PMID |
| Holt IJ, Lorimer HE, Jacobs HT Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA. Cell 2000 ;100(5)515-24 PMID |
| Jacobs HT, Holt IJ The np 3243 MELAS mutation: damned if you aminoacylate, damned if you don't. Hum Mol Genet 2000 ;9(4)463-5 PMID |
| Lehtinen SK, Hance N, El Meziane A, Juhola MK, Juhola KM, Karhu R, Spelbrink JN, Holt IJ, Jacobs HT Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA. Genetics 2000 ;154(1)363-80 PMID |
| Desper R, Jiang F, Kallioniemi OP, Moch H, Papadimitriou CH, Schaffer AA Distance-based reconstruction of tree models for oncogenesis. J Comput Biol 2000 ;7(6)789-803 PMID |
| Wolf M, El-Rifai W, Tarkkanen M, Kononen J, Serra M, Eriksen EF, Elomaa I, Kallioniemi A, Kallioniemi OP, Knuutila S Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet Cytogenet 2000 ;123(2)128-32 PMID |
| Schleutker J, Matikainen M, Smith J, Koivisto P, Baffoe-Bonnie A, Kainu T, Gillanders E, Sankila R, Pukkala E, Carpten J, Stephan D, Tammela T, Brownstein M, Bailey-Wilson J, Trent J, Kallioniemi OP A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. Clin Cancer Res 2000 ;6(12)4810-5 PMID |
| Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, Kallioniemi OP, Kononen J Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000 ;60(23)6617-22 PMID |
| Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000 ;60(22)6503-9 PMID |
| Mononen N, Syrjakoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene. Cancer Res 2000 ;60(22)6479-81 PMID |
| Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000 ;60(21)6111-5 PMID |
| Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. J Urol 2000 ;164(6)1992-5 PMID |
| Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjakoski K, Kainu T, Vahteristo P, Krahe R, Paakkonen K, Hartikainen J, Blomqvist C, Lopponen T, Holli K, Ryynanen M, Butzow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet 2000 ;8(10)757-63 PMID |
| Matikainen MP, Sankila R, Schleutker J, Kallioniemi OP, Pukkala E Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients. Int J Cancer 2000 ;88(2)307-12 PMID |
| Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 2000 ;92(18)1529-31 PMID |
| Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP, Sauter G High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000 ;157(3)787-94 PMID |
| Forozan F, Mahlamaki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A, Kallioniemi OP Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 2000 ;60(16)4519-25 PMID |
| Kainu T, Juo SH, Desper R, Schaffer AA, Gillanders E, Rozenblum E, Freas-Lutz D, Weaver D, Stephan D, Bailey-Wilson J, Kallioniemi OP, Tirkkonen M, Syrjakoski K, Kuukasjarvi T, Koivisto P, Karhu R, Holli K, Arason A, Johannesdottir G, Bergthorsson JT, Johannsdottir H, Egilsson V, Barkardottir RB, Johannsson O, Haraldsson K, Sandberg T, Holmberg E, Gronberg H, Olsson H, Borg A, Vehmanen P, Eerola H, Heikkila P, Pyrhonen S, Nevanlinna H Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A 2000 ;97(17)9603-8 PMID |
| Barlund M, Forozan F, Kononen J, Bubendorf L, Chen Y, Bittner ML, Torhorst J, Haas P, Bucher C, Sauter G, Kallioniemi OP, Kallioniemi A Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst 2000 ;92(15)1252-9 PMID |
| Eary JF, Krohn KA Positron emission tomography: imaging tumor response. Eur J Nucl Med 2000 ;27(12)1737-9 PMID |
| Krohn K, Frese P, Florke U Biomimetic synthesis of the racemic angucyclinones of the aquayamycin and WP 3688-2 types. Chemistry 2000 ;6(21)3887-96 PMID |
| Heitzer T, Krohn K, Albers S, Meinertz T Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 2000 ;43(11)1435-8 PMID |
| Hannula PM, Antonen JA, Saha HH, Koivisto AM, Krohn KJ, Pasternack AI Constant, but not pulsed calcitriol suppresses hemodialysis patients' antigen-induced lymphocyte proliferation. Nephron 2000 ;86(2)139-44 PMID |
| Krohn K, Wohlgemuth S, Gerber H, Paschke R Hot microscopic areas of iodine-deficient euthyroid goitres contain constitutively activating TSH receptor mutations. J Pathol 2000 ;192(1)37-42 PMID |
| Heino M, Peterson P, Sillanpaa N, Guerin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Jenkinson EJ, Naquet P, Krohn KJ RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol 2000 ;30(7)1884-93 PMID |
| Peterson P, Uibo R, Krohn KJ Adrenal autoimmunity: results and developments. Trends Endocrinol Metab 2000 ;11(7)285-90 PMID |
| Miedlich S, Krohn K, Lamesch P, Muller A, Paschke R Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism. Eur J Endocrinol 2000 ;143(1)47-54 PMID |
| Aapola U, Kawasaki K, Scott HS, Ollila J, Vihinen M, Heino M, Shintani A, Kawasaki K, Minoshima S, Krohn K, Antonarakis SE, Shimizu N, Kudoh J, Peterson P Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 2000 ;65(3)293-8 PMID |
| Reimand K, Peterson P, Hyoty H, Uibo R, Cooke I, Weetman AP, Krohn KJ 3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure. J Clin Endocrinol Metab 2000 ;85(6)2324-6 PMID |
| Allen E, Krohn K Adverse reaction to Hylan GF-20. J Rheumatol 2000 ;27(6)1572 PMID |
| Krohn K, Bernhard S, Florke U, Hayat N Biomimetic-type synthesis of benzo[a]naphthacenequinones related to pradimicinone. J Org Chem 2000 ;65(10)3218-22 PMID |
| Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Krohn K, Peterson P The autoimmune regulator protein has transcriptional transactivating properties and interacts with the common coactivator CREB-binding protein. J Biol Chem 2000 ;275(22)16802-9 PMID |
| Manninen A, Renkema GH, Saksela K Synergistic activation of NFAT by HIV-1 nef and the Ras/MAPK pathway. J Biol Chem 2000 ;275(22)16513-7 PMID |
| Renkema GH, Saksela K Interactions of HIV-1 NEF with cellular signal transducing proteins. Front Biosci 2000 ;5D268-83 PMID |
| Pesu M, Takaluoma K, Aittomaki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6. Blood 2000 ;95(2)494-502 PMID |
| Kotaja N, Aittomaki S, Silvennoinen O, Palvimo JJ, Janne OA ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation. Mol Endocrinol 2000 ;14(12)1986-2000 PMID |
| Ekman N, Arighi E, Rajantie I, Saharinen P, Ristimaki A, Silvennoinen O, Alitalo K The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 2000 ;19(36)4151-8 PMID |
| Aittomaki S, Pesu M, Groner B, Janne OA, Palvimo JJ, Silvennoinen O Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes. J Immunol 2000 ;164(11)5689-97 PMID |
| Saharinen P, Takaluoma K, Silvennoinen O Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol Cell Biol 2000 ;20(10)3387-95 PMID |
| Kovanen PE, Junttila I, Takaluoma K, Saharinen P, Valmu L, Li W, Silvennoinen O Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells. Blood 2000 ;95(5)1626-32 PMID |
| Paukku K, Valgeirsdottir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem J 2000 ;345 Pt 3759-66 PMID |
| Pesu M, Takaluoma K, Aittomaki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6. Blood 2000 ;95(2)494-502 PMID |
| Kajander OA, Rovio AT, Majamaa K, Poulton J, Spelbrink JN, Holt IJ, Karhunen PJ, Jacobs HT Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states. Hum Mol Genet 2000 ;9(19)2821-35 PMID |
| Jacobs HT, Lehtinen SK, Spelbrink JN No sex please, we're mitochondria: a hypothesis on the somatic unit of inheritance of mammalian mtDNA. Bioessays 2000 ;22(6)564-72 PMID |
| Spelbrink JN, Toivonen JM, Hakkaart GA, Kurkela JM, Cooper HM, Lehtinen SK, Lecrenier N, Back JW, Speijer D, Foury F, Jacobs HT In vivo functional analysis of the human mitochondrial DNA polymerase POLG expressed in cultured human cells. J Biol Chem 2000 ;275(32)24818-28 PMID |
| Lehtinen SK, Hance N, El Meziane A, Juhola MK, Juhola KM, Karhu R, Spelbrink JN, Holt IJ, Jacobs HT Genotypic stability, segregation and selection in heteroplasmic human cell lines containing np 3243 mutant mtDNA. Genetics 2000 ;154(1)363-80 PMID |
| Nupponen NN, Visakorpi T Molecular cytogenetics of prostate cancer. Microsc Res Tech 2000 ;51(5)456-63 PMID |
| Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. J Urol 2000 ;164(6)1992-5 PMID |
| Lindfors K, Halttunen T, Huotari P, Nupponen N, Vihinen M, Visakorpi T, Maki M, Kainulainen H Identification of novel transcription factor-like gene from human intestinal cells. Biochem Biophys Res Commun 2000 ;276(2)660-6 PMID |
| Hernes EH, Linja M, Fossa SD, Visakorpi T, Berner A, Winderen M, Koivisto PA Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors. BJU Int 2000 ;86(3)240-7 PMID |
| Koski T, Karhu R, Visakorpi T, Vilpo L, Knuutila S, Vilpo J Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance. Eur J Haematol 2000 ;65(1)32-9 PMID |
| Nupponen NN, Isola J, Visakorpi T Mapping the amplification of EIF3S3 in breast and prostate cancer. Genes Chromosomes Cancer 2000 ;28(2)203-10 PMID |
Biolääketieteellisen teknologian yksikkö
Biokatu 8
33520 Tampere, Finland
Biokatu 8
33520 Tampere, Finland
